Daniel A. Maxenberger Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

University of Arkansas at Fayetteville

unknown

2 h-index 2 pubs 12 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Daniel A. Maxenberger's research focuses on the application of CRISPR-Cas9 genome editing technology. His work has explored the delivery challenges associated with using this technology for genetic disorders such as Duchenne muscular dystrophy. Additionally, he has investigated methods to optimize the expression of recombinant Cas9 protein in E. coli BL21(DE3) strains. This optimization aims to enhance protein purification efficiency, a critical step for successful genome editing applications. Maxenberger has published two papers in this area and has a citation count of 12, with an h-index of 2. He collaborates with researchers from the University of Arkansas at Little Rock, including Christopher E. Nelson, Made Harumi Padmaswari, and Shilpi Agrawal, as well as Morgan Reese from the University of Arkansas at Fayetteville.

Metrics

  • h-index: 2
  • Publications: 2
  • Citations: 12

Selected Publications

  • Optimizing Recombinant Cas9 Expression: Insights from E. coli BL21(DE3) Strains for Enhanced Protein Purification and Genome Editing (2024) DOI
  • Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy (2023) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics